DOI: 10.1055/s-00000075

Seminars in Respiratory and Critical Care Medicine

References

Enblad G, Hagberg H, Erlanson M. , et al.
A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas.

Blood 2004;
103 (08) 2920-2924

Download Bibliographical Data

Search in:
Access:
Access: